Citadel Advisors’s SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an SCPE.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-109,287
Closed -$148K 14002
2020
Q4
$148K Buy
109,287
+169
+0.2% +$209 ﹤0.01% 9955
2020
Q3
$125K Buy
109,118
+13
+0% +$14 ﹤0.01% 9135
2020
Q2
$118K Sell
109,105
-5,450
-5% -$5.55K ﹤0.01% 8900
2020
Q1
$109K Buy
114,555
+1,101
+1% +$1.1K ﹤0.01% 8579
2019
Q4
$109K Buy
113,454
+78,597
+225% +$85K ﹤0.01% 8514
2019
Q3
$42K Buy
+34,857
New +$41.1K ﹤0.01% 8753

Other funds holding SCPE.WS

Citadel Advisors's SCPE.WS Position: Q1 2021 in Review

Citadel Advisors sold out of SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an (SCPE.WS) in Q1 2021, closing a stake of 109,287 shares — an estimated $148K sold.

Citadel Advisors first reported a position in SCPE.WS in Q3 2019 and held it in 6 quarters. The position peaked at $148K in Q4 2020. 25 funds tracked by Wall St. Rank hold SCPE.WS as of Q1 2021.

  • Citadel Advisors reported no remaining SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position as of Q1 2021 after selling out during the quarter.
  • Citadel Advisors sold 109,287 SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an shares in Q1 2021, an estimated $148K.
  • Citadel Advisors first reported a position in SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an in Q3 2019 and held it in 6 quarters.
  • Citadel Advisors's SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position peaked at $148K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an as of Q1 2021.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.